SEC Form 3 · accession 0001144204-16-085395
IMMUNE PHARMACEUTICALS INC · IMNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey Paley
Director
Period of report
Feb 23, 2016
Accepted (ET)
Mar 1, 2016 · 6:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001208261
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 8,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (Right to buy)F1 | $2.01 | holding | — | — | — | — | May 19, 2025 | Common Stock | 60,000 | — | D |
Explanation of responses
- F1The securities vest quarterly over a one year-period beginning on June 30, 2015.
Remarks
Exhibit List - Exhibit 24 - Power of Attorney